February 9, 2024 — Injection of a substance to block an artery feeding the dura (protective sack around the brain) — along with surgery to remove pooled blood — reduced the risk that patients will require repeat surgery compared to surgical drainage alone.

February 9, 2024 — MIVI Neuroscience, Inc. announced the primary endpoint results of its EvaQ Trial, a prospective, multi-center, global, single arm, FDA-regulated IDE trial study to evaluate the safety and effectiveness of the MIVI Q Revascularization System for treating acute ischemic stroke.

February 8, 2024 — The American Heart Association (AHA), currently celebrating its centennial year, announced that it is providing $450,000 in grants to assess its new risk prediction tool among diverse race, age, geographic and socioeconomic groups.

February 7, 2024 — According to results from a multi-center trial in the United States, called Zero Degree Head Positioning in Acute Large Vessel Ischemic Stroke, or ZODIAC, while hospital beds for stroke patients are typically elevated at the head, a flat head position before surgical removal of a blood clot in the brain (thrombectomy) may lead to

February 7, 2024 — Medtronic announced new cost-effectiveness data from the STROKE AF clinical study, which showed that continuous monitoring with the Medtronic 

February 7, 2024 — Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover movement in their arms and hands and maintain these improvements for one year, according to a study to be presented at the 

February 7, 2024 — The Consumer Technology Association (CTA) and the American College of Cardiology (ACC) are announcing the release of their second industry framework for the use of consumer cardiovascular technology solutions in the screening and diagnosis for cardiovascular conditions.  This new document builds off of the previously published 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now